NRx Pharmaceuticals
(NASDAQ) NRXP
NRx Pharmaceuticals Financials at a Glance
Market Cap
$58.96M
Revenue (TTM)
$242.00K
Net Income (TTM)
$38.06M
EPS (TTM)
$-2.35
P/E Ratio
-0.79
Dividend
$0.00
Beta (Volatility)
0.97 (Low)
Dividend
$0.00
Beta (Volatility)
0.97 (Low)
Price
$1.82
Volume
25,213
Open
$1.82
Price
$1.82
Volume
25,213
Open
$1.82
Previous Close
$1.82
Daily Range
$1.79 - $1.91
52-Week Range
$1.58 - $3.84
Dividend
$0.00
Beta (Volatility)
0.97 (Low)
Price
$1.82
Volume
25,213
Open
$1.82
Previous Close
$1.82
Daily Range
$1.79 - $1.91
52-Week Range
$1.58 - $3.84
NRXP News
NRXP: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout NRx Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareCEO
Jonathan C. Javitt, MD
Website
www.nrxpharma.comHeadquarters
Wilmington, DE 19801, US
NRXP Financials
Key Financial Metrics (TTM)
Gross Margin
60%
Operating Margin
-63%
Net Income Margin
-157%
Return on Equity
0%
Return on Capital
60%
Return on Assets
-3%
Earnings Yield
-1.27%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$58.96M
Shares Outstanding
31.87M
Volume
25.21K
Short Interest
0.00%
Avg. Volume
990.30K
Financials (TTM)
Gross Profit
$5.00K
Operating Income
$19.70M
EBITDA
$24.04M
Operating Cash Flow
$10.64M
Capital Expenditure
$0.00
Free Cash Flow
$10.64M
Cash & ST Invst.
$1.44M
Total Debt
$6.58M
NRx Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$242.00K
N/A
Gross Profit
$145.00K
+7350.0%
Gross Margin
59.92%
N/A
Market Cap
$58.96M
N/A
Market Cap/Employee
$29.48M
N/A
Employees
2
N/A
Net Income
$5.89M
-262.9%
EBITDA
$5.85M
-260.7%
Quarterly Fundamentals
Net Cash
$6.84M
+236.1%
Accounts Receivable
$239.00K
+3883.3%
Inventory
$0.00
N/A
Long Term Debt
$158.00K
-94.7%
Short Term Debt
$189.00K
-94.9%
Return on Assets
-2.54%
N/A
Return on Invested Capital
59.52%
N/A
Free Cash Flow
$2.89M
-25.4%
Operating Cash Flow
$2.89M
-25.4%